Herbal Monograph
Turkey tail
Trametes versicolor (L.) Lloyd
Polyporaceae
Potent immune-modulating medicinal mushroom with the strongest clinical evide...
Overview
Plant Description
Turkey tail is a wood-decaying polypore fungus producing thin, leathery, bracket-shaped (semicircular to fan-shaped) fruiting bodies 2-10 cm wide and 1-3 mm thick. The upper surface is characteristically marked with concentric zones of contrasting colors -- bands of brown, tan, gray, cream, blue, green, and near-black -- giving a strikingly variegated appearance that resembles the fanned tail of a wild turkey. The surface texture is finely velvety (tomentose) to smooth. The undersurface (hymenium) is white to pale cream and covered in tiny, round to angular pores (3-5 per mm), which distinguish it from the false turkey tail (Stereum ostrea), which has a smooth underside. Fruiting bodies grow in overlapping clusters, tiers, or rosettes on dead and decaying hardwood logs, stumps, and fallen branches. The flesh is thin, tough, and pliant when fresh, becoming rigid when dried. The organism is a white-rot fungus that decomposes lignin and cellulose in dead wood. Spore print is white. The species is extremely common and one of the most frequently encountered bracket fungi worldwide.
Habitat
Grows on dead and decaying hardwood throughout temperate and subtropical forests. Most commonly found on fallen logs, dead standing trunks, stumps, and large branches of deciduous hardwoods including oak (Quercus), beech (Fagus), birch (Betula), maple (Acer), and willow (Salix). Occasionally found on conifers. Thrives in moist, shaded woodland environments but tolerant of a wide range of conditions. Fruits year-round in temperate climates, with peak fruiting in autumn. Perennial fruiting bodies can persist for months to years on suitable substrates.
Distribution
Cosmopolitan distribution. Found on every continent except Antarctica. Abundant throughout temperate forests of North America, Europe, and Asia. Also present in tropical and subtropical regions of Central and South America, Africa, and Australasia. Particularly prominent in the deciduous and mixed forests of the Pacific Northwest (North America), Japan, China, and northern Europe. One of the most widely distributed and easily recognizable polypore fungi in the world.
Parts Used
Fruiting body (whole dried bracket)
Preferred: Hot water extract (decoction or spray-dried extract powder); standardized extract (capsule or tablet); PSK/Krestin (pharmaceutical-grade protein-bound polysaccharide)
The dried fruiting body is the traditional medicinal part used in Chinese and Japanese herbal medicine. Contains the full spectrum of bioactive polysaccharides (beta-glucans), phenolic compounds, ergosterol, and other metabolites. Hot water extraction is necessary to liberate cell-wall-bound polysaccharides from the chitin matrix, as crude dried fruiting body powder has limited bioavailability. PSK (polysaccharide-K / Krestin) is extracted from cultured mycelium on grain substrate but the fruiting body is the traditional form. Chinese Pharmacopoeia lists Yun zhi (cloud mushroom) as the dried fruiting body.
Mycelium (cultured biomass)
Preferred: PSP standardized extract (capsule); mycelial biomass powder (capsule); liquid fermentation extract
Mycelium grown via deep-layer liquid fermentation or on solid substrate is the source of PSP (polysaccharopeptide), the primary bioactive compound studied in Chinese clinical trials. Mycelial biomass products include both the mycelium itself and extracellular metabolites secreted into the culture medium. Some commercial supplements use mycelium grown on grain substrate (myceliated grain), though the bioactive polysaccharide content may be diluted by residual grain starch. Pure mycelial extracts standardized to beta-glucan or PSP content are preferred for therapeutic applications.
Key Constituents
Protein-bound polysaccharides
PSK and PSP are the principal bioactive compounds responsible for the immunomodulating and anticancer adjuvant activity of T. versicolor. They activate both innate immunity (macrophages, NK cells, dendritic cells) and adaptive immunity (T helper cells, cytotoxic T lymphocytes) through binding to Toll-like receptor 2 (TLR2) and complement receptor 3 (CR3). PSK has been the subject of over 400 clinical studies in Japan, primarily as an adjuvant to chemotherapy for gastric, colorectal, esophageal, and lung cancers. PSP has been studied in multiple Chinese RCTs. These compounds are the most clinically validated immunotherapeutic agents derived from any medicinal mushroom.
Beta-glucans (non-protein-bound)
Beta-glucans are the foundational immunostimulatory compounds in T. versicolor. They prime the innate immune system through pattern recognition receptors (Dectin-1, CR3, TLR2/6), enhancing the body's surveillance and response to pathogens and abnormal cells. Hot water extraction is essential to liberate beta-glucans from the chitin cell wall matrix. Standardization of T. versicolor supplements to beta-glucan content (typically 25-50%) is an important quality marker.
Sterols and terpenoids
Sterols and triterpenoids contribute to the anti-inflammatory and hepatoprotective actions of T. versicolor. Ergosterol's role as a provitamin D2 precursor adds nutritional value, particularly for UV-exposed dried mushroom preparations. These compounds are best extracted with ethanol or dual-extraction methods (hot water + ethanol).
Phenolic compounds
Phenolic compounds are responsible for the significant antioxidant activity of T. versicolor extracts. T. versicolor ranks among the highest of medicinal mushrooms for total phenolic content and ORAC (Oxygen Radical Absorbance Capacity) antioxidant value. The phenolic fraction contributes to hepatoprotective and anti-inflammatory effects and may synergize with polysaccharide immunomodulatory activity.
Other bioactive compounds
Additional compounds expand the therapeutic profile beyond the primary polysaccharide immunomodulators. The prebiotic effects of fungal chitin and cell wall components on gut microbiota are an active area of research, with preliminary evidence suggesting T. versicolor supplementation favorably modulates the gut microbiome composition in breast cancer patients (Torkelson et al. 2012).
Herbal Actions
Modulates and balances immune function
The defining pharmacological action of T. versicolor. PSK and PSP modulate both innate and adaptive immune responses through Toll-like receptor 2 (TLR2), Dectin-1, and complement receptor 3 (CR3) binding. Effects include enhanced NK cell cytotoxicity, increased dendritic cell maturation and antigen presentation, augmented cytotoxic T lymphocyte activity, upregulation of Th1 cytokines (IL-2, IFN-gamma, TNF-alpha), and modulation of regulatory T cell function. The immunomodulating action is bidirectional -- it can both stimulate underactive immune responses and help normalize overactive inflammatory states, distinguishing it from simple immunostimulation. Over 400 clinical studies on PSK in Japan and multiple RCTs on PSP in China support this action. Japanese regulatory approval of PSK (Krestin) as a prescription immunotherapy adjuvant since 1977 represents the highest level of validation for any mushroom-derived compound.
[4, 6, 7, 9]Prevents or slows oxidative damage to cells
T. versicolor demonstrates strong antioxidant activity attributable to its high phenolic content (gallic acid, protocatechuic acid, catechins), ergosterol and ergosterol peroxide, and polysaccharide components. Hot water and ethanolic extracts show significant DPPH, ABTS, and superoxide radical scavenging activity. The antioxidant action is considered complementary to immunomodulating activity, helping to protect immune cells from oxidative damage and reducing oxidative stress associated with chronic disease and chemotherapy.
[3, 11]Protects the liver from damage
Preclinical studies demonstrate hepatoprotective activity of T. versicolor polysaccharides and triterpenoids against various hepatotoxins (carbon tetrachloride, acetaminophen). Mechanisms include reduction of hepatic oxidative stress, inhibition of lipid peroxidation, preservation of glutathione levels, and attenuation of inflammatory cytokine production in liver tissue. In traditional Chinese medicine, yun zhi is used for chronic hepatitis and liver support. The hepatoprotective action is considered secondary to the primary immunomodulating activity.
[3, 10]Reduces inflammation
PSK and PSP demonstrate anti-inflammatory activity through modulation of NF-kB signaling, reduction of pro-inflammatory cytokines (IL-6, TNF-alpha) in chronic inflammatory contexts, and inhibition of COX-2 expression. Ergosterol and ergosterol peroxide contribute additional anti-inflammatory mechanisms. The anti-inflammatory action in T. versicolor is nuanced -- it can suppress chronic, pathological inflammation while simultaneously enhancing acute immune activation against pathogens and tumors.
[9, 10]Kills or inhibits the growth of microorganisms
In vitro studies demonstrate antiviral activity against HPV (human papillomavirus), HSV (herpes simplex virus), and HIV. PSP has shown inhibitory activity against HIV-1 reverse transcriptase in vitro. Antifungal and antibacterial activity has been demonstrated against several pathogens including E. coli, Staphylococcus aureus, and Candida albicans. The antimicrobial action is considered secondary to immune enhancement rather than direct pathogen killing at typical doses.
[1, 3]Helps the body adapt to stress and restore homeostasis
While not a classic adaptogen in the Brekhman definition, T. versicolor demonstrates adaptogenic-like properties through its bidirectional immune modulation and support for homeostatic balance during physiological stress. In traditional Chinese medicine, yun zhi is classified as a tonic that strengthens the constitution and supports recovery from illness. The adaptogenic quality is reflected in its ability to enhance resilience during chemotherapy without overstimulating immune function.
[2, 3]Therapeutic Indications
Immune System
Cancer immunotherapy adjunct (gastric, colorectal, breast, lung)
The primary clinical indication with the strongest evidence base. PSK has been used as an adjuvant to chemotherapy for gastric and colorectal cancer in Japan since 1977. A 2006 meta-analysis of RCTs (Sakamoto et al.) found that PSK adjuvant therapy significantly improved 5-year overall survival in patients with curatively resected colorectal cancer (HR 0.71, 95% CI 0.55-0.90, P < 0.01). Multiple RCTs demonstrate improved survival when PSK is combined with chemotherapy for gastric cancer (hazard ratio for death approximately 0.67-0.73). Nakazato et al. (1994) RCT (n=462) demonstrated PSK + chemotherapy significantly improved 5-year disease-free survival in stage III colorectal cancer. PSP has been studied in Chinese RCTs as a chemotherapy adjunct for gastric, esophageal, and lung cancers with positive results on immune parameters and quality of life. A phase I trial at Bastyr University (Torkelson et al. 2012) demonstrated safety and immunological activity of T. versicolor in breast cancer patients post-chemotherapy.
[4, 5, 6, 9]Immune deficiency and recurrent infections
Enhancement of innate and adaptive immune function through NK cell activation, dendritic cell maturation, and T lymphocyte proliferation supports the use of T. versicolor for immune deficiency states. Clinical studies show increased lymphocyte counts, NK cell activity, and cytokine production in immunocompromised patients receiving PSK or PSP. Used in traditional Chinese medicine for patients with weakened constitution following chronic illness.
[3, 7, 9]HPV-related infections (cervical, oral)
Preliminary clinical evidence suggests T. versicolor supplementation may enhance immune-mediated HPV clearance. The mechanism is thought to be indirect through enhanced immune surveillance (NK cell and cytotoxic T lymphocyte activation) rather than direct antiviral activity. More rigorous controlled trials are needed.
[1, 3]Digestive System
Gut microbiome support and dysbiosis
The Bastyr University phase I breast cancer trial (Torkelson et al. 2012) included gut microbiome analysis showing that T. versicolor supplementation favorably modulated gut bacterial composition, increasing Bifidobacterium and Lactobacillus populations while modifying Firmicutes-to-Bacteroidetes ratio. Fungal polysaccharides and chitin may serve as prebiotics. This is a rapidly emerging area of research linking mushroom polysaccharides to gut-immune axis modulation.
[3, 6]Chemotherapy-induced gastrointestinal side effects
Multiple clinical studies on PSK and PSP as chemotherapy adjuncts report improved appetite, reduced nausea, and better maintenance of body weight in patients receiving concurrent T. versicolor supplementation. Quality of life scores in the digestive domain are consistently improved. These benefits may be secondary to immune support and reduced inflammation rather than direct GI action.
[4, 7]Hepatobiliary System
Chronic hepatitis B and C (adjunctive support)
In traditional Chinese medicine, yun zhi is used for chronic hepatitis and liver support. Clinical studies in China have evaluated PSP as an adjunct to conventional treatment for chronic hepatitis B, showing improvements in liver function parameters (ALT, AST), viral load markers, and immune cell counts. PSP has been reported to improve seroconversion rates when added to standard antiviral therapy for chronic hepatitis B.
[7, 10]Hepatoprotection during chemotherapy
PSK and PSP supplementation during chemotherapy has been associated with preservation of liver function markers and reduced chemotherapy-induced hepatotoxicity in clinical studies. The hepatoprotective mechanism involves reduction of oxidative stress, modulation of inflammatory pathways, and enhancement of hepatocyte regeneration.
[9, 10]Respiratory System
Upper respiratory infections (prevention and recovery)
Traditional use in Chinese medicine for respiratory infections, cough, and dyspnea. The immunomodulating action is proposed to enhance mucosal immunity and support recovery from respiratory infections. Limited direct clinical evidence for standalone respiratory indications, but the immunostimulant properties are relevant to respiratory defense.
[2, 3]Lung cancer adjunctive support
PSK has been studied as an adjuvant to chemotherapy in non-small cell lung cancer (NSCLC). Fritz et al. (2015) systematic review identified multiple Japanese studies demonstrating improved survival and immune parameters when PSK was added to standard chemotherapy regimens for NSCLC. PSP has also been studied in Chinese trials for lung cancer support.
[7, 9]Lymphatic System
Lymphocyte recovery post-chemotherapy or immunosuppression
Clinical studies consistently demonstrate that PSK and PSP supplementation accelerates lymphocyte recovery following chemotherapy-induced lymphopenia. Increased CD4+ and CD8+ T cell counts, enhanced NK cell activity, and improved CD4/CD8 ratios have been documented. The Bastyr University phase I trial (Torkelson et al. 2012) specifically demonstrated dose-dependent increases in NK cell functional activity in breast cancer patients.
[6, 7, 9]Energetics
Temperature
cool
Moisture
slightly dry
Taste
Tissue States
hot/excitation, damp/stagnation
In traditional Chinese medicine, yun zhi is classified as sweet, slightly bitter, and slightly cold, entering the Liver and Spleen meridians. It clears damp-heat, strengthens the spleen, and resolves toxins. In Western herbal energetics, turkey tail is considered cool to neutral and slightly drying, making it appropriate for conditions with signs of heat (inflammation, infection) and damp stagnation (congestion, tumor growth, sluggish immune response). The bland taste reflects its polysaccharide-rich composition, while the mild bitterness indicates its affinity for the hepatobiliary and digestive systems. The cooling, drying quality suggests it is most indicated for warm, damp constitutions or conditions -- consistent with its use in cancer support (damp/stagnation with heat) and chronic infection (damp-heat). CAVEAT: Herbal energetics are interpretive frameworks within Western and traditional Chinese herbalism, not standardized across all practitioners.
Traditional Uses
Traditional Chinese Medicine (TCM)
- Yun zhi used for clearing damp-heat and resolving toxins
- Chronic hepatitis and liver disease support
- Strengthening the spleen and supplementing qi in weakened constitutions
- Chronic cough, dyspnea, and respiratory congestion
- Leukorrhea and other damp-heat conditions of the lower burner
- Cancer support and recovery from chronic illness
- Used as a tonic for convalescence and debility
"Yun zhi (cloud mushroom) has been used in traditional Chinese medicine for centuries as a tonic and restorative. It is classified as sweet and slightly cold, entering the Liver and Spleen channels. The Compendium of Materia Medica (Bencao Gangmu, Li Shizhen, 1578) references polypore fungi used for strengthening the body, nourishing the essence, and calming the spirit. The Chinese Pharmacopoeia lists yun zhi for dispelling dampness, reducing phlegm, treating chronic cough, and resolving toxins."
Traditional Japanese medicine (Kampo and folk medicine)
- Kawaratake (riverbank mushroom) used as a general health tonic tea
- Cancer prevention and support alongside conventional treatment
- Strengthening the immune system during seasonal illness
- Liver protective tonic
- Recovery from chronic fatigue and debility
"In Japan, kawaratake (T. versicolor) has a long folk tradition as a health tonic brewed as a decoction tea. The modern pharmaceutical development of PSK (Krestin) in the 1970s was directly inspired by a chemical engineer's observation that his neighbor, who regularly drank kawaratake tea, recovered from advanced gastric cancer against all medical expectations. This anecdotal observation led to systematic research at Kureha Chemical Industry Co. and the eventual development of PSK as a prescription cancer immunotherapy drug, approved by the Japanese Health Ministry in 1977."
European and North American folk medicine
- Decoction of dried brackets used as a general health tonic
- Poultice of fresh or reconstituted fungus applied to wounds and skin infections
- Tea used for respiratory and digestive complaints
- Used as a convalescence tonic in rural folk traditions
"While turkey tail did not attain the prominence in Western herbal traditions that it holds in East Asian medicine, European and North American folk traditions documented the use of bracket fungi (polypores) including T. versicolor as tonics and wound treatments. Indigenous North American peoples used various polypore fungi for medicinal purposes, and the widespread availability of turkey tail made it a commonly foraged species for household remedies."
Modern integrative oncology
- Adjuvant immunotherapy alongside conventional chemotherapy and radiation
- Post-surgical immune recovery support
- Quality of life improvement during cancer treatment
- Immune surveillance support in cancer remission
- Gut microbiome restoration following chemotherapy and antibiotics
"Turkey tail has become one of the most widely recommended medicinal mushrooms in integrative oncology practice. Paul Stamets, the renowned mycologist, has championed its use in integrative cancer care, and it is included in many naturopathic and integrative oncology protocols. The Society for Integrative Oncology recognizes mushroom-derived compounds including PSK among promising natural products for cancer support. It is one of the few natural products with full pharmaceutical approval (PSK in Japan) as a cancer immunotherapy adjuvant, and the NIH funded the Bastyr University phase I trial investigating whole mushroom preparations in breast cancer patients."
Modern Research
Meta-analysis of PSK as adjuvant immunotherapy for colorectal cancer
Systematic review and meta-analysis of centrally randomized controlled trials evaluating PSK as an adjuvant to chemotherapy for curatively resected colorectal cancer patients in Japan.
Findings: The meta-analysis pooled data from three randomized controlled trials involving 1,159 patients. PSK adjuvant therapy combined with chemotherapy significantly improved 5-year overall survival compared to chemotherapy alone (risk ratio for overall survival: HR 0.71, 95% CI 0.55-0.90, P < 0.01). Disease-free survival was also significantly improved. The benefit was most pronounced in patients with stage III (Dukes' C) colorectal cancer. The mechanism of benefit was attributed to immune enhancement (increased NK cell activity and lymphocyte counts) alongside antitumor effects.
Limitations: All included studies were conducted in Japan. Heterogeneity in chemotherapy regimens across trials. Publication bias cannot be excluded. PSK is not widely available outside Japan. The specific PSK formulation (Krestin) may not be equivalent to commercial T. versicolor supplements.
[4]
PSK adjuvant therapy for curatively resected gastric cancer (landmark RCT)
Multi-center randomized controlled trial evaluating oral PSK (3 g/day) combined with chemotherapy versus chemotherapy alone in 462 patients with curatively resected gastric cancer, followed for a minimum of 5 years.
Findings: PSK + chemotherapy significantly improved both 5-year disease-free survival and 5-year overall survival compared to chemotherapy alone. The improvement in survival was consistent across subgroup analyses including stage III disease and patients with vascular invasion. Polymorphonuclear leukocyte activity and lymphocyte counts were significantly higher in the PSK group, supporting an immune-mediated mechanism of action.
Limitations: Japanese patient population exclusively. Single specific chemotherapy regimen. Open-label design for PSK administration. Results may not be generalizable to non-Japanese populations or different chemotherapy regimens.
[5]
Meta-analysis of PSK adjuvant immunochemotherapy for gastric cancer
Meta-analysis of randomized controlled trials evaluating PSK combined with chemotherapy versus chemotherapy alone in patients with curatively resected gastric cancer in Japan.
Findings: Pooled analysis demonstrated that PSK adjuvant therapy significantly improved overall survival in gastric cancer patients. The survival benefit was most pronounced in patients with advanced (stage III) disease and those with vascular invasion. A 10-15% absolute improvement in 5-year survival was observed across multiple trials. Immunological studies confirmed enhanced NK cell activity and T lymphocyte function in PSK-treated patients.
Limitations: All studies conducted in Japan. Heterogeneity in chemotherapy protocols. Older study designs may not meet current reporting standards. Generalizability to Western populations and modern chemotherapy regimens is uncertain.
[8]
Phase I trial of Turkey Tail mushroom in breast cancer patients (Bastyr University / NIH)
Phase I dose-escalation clinical trial evaluating the safety and immunological effects of orally administered Trametes versicolor (whole mushroom fruiting body powder) at doses of 3, 6, and 9 g/day in 11 women with breast cancer (stage I-III) who had completed standard chemotherapy and radiation therapy.
Findings: T. versicolor was well tolerated at all dose levels with no dose-limiting toxicities. Immunological analysis revealed dose-dependent increases in NK cell functional activity (CD56+CD16+ lymphocytes) at 6 and 9 g/day. The 9 g/day dose also increased CD8+ T cell counts. Gut microbiome analysis showed favorable shifts in bacterial populations, including increases in Bifidobacterium and Lactobacillus species. This was the first US clinical trial to confirm immunological activity of whole-mushroom T. versicolor supplements in cancer patients.
Limitations: Very small sample size (n=11). Phase I design (safety and dose-finding only, not efficacy). No control group. Single cancer type (breast). Whole mushroom powder rather than standardized PSK or PSP extract. Short treatment duration.
[6]
Systematic review of Coriolus versicolor extracts for lung cancer
Systematic review of preclinical and clinical evidence for Coriolus versicolor (T. versicolor) extracts, including PSK and PSP, as anticancer agents specifically for lung cancer, encompassing both in vitro/in vivo studies and human clinical trials.
Findings: The review identified strong preclinical evidence for direct antitumor activity (inhibition of proliferation, induction of apoptosis, anti-angiogenic effects) and potent immunomodulatory activity in lung cancer models. Clinical evidence from Japanese and Chinese trials supported improved survival, immune parameters, and quality of life when PSK or PSP were used as adjuncts to conventional cancer treatment. The review concluded that T. versicolor extracts represent one of the most evidence-based natural product approaches to cancer immunotherapy and warrant further investigation in large-scale Western clinical trials.
Limitations: Heterogeneity across included studies (different extracts, doses, cancer types, chemotherapy regimens). Most clinical trials conducted in East Asia. Potential publication bias. Difficulty comparing PSK, PSP, and whole-mushroom preparations. Quality of some older Japanese studies does not meet current reporting standards.
[9]
PSP double-blind RCT in advanced non-small cell lung cancer
Double-blind, placebo-controlled randomized trial evaluating PSP (polysaccharopeptide from T. versicolor) as an adjunct to conventional treatment in patients with advanced (stage III-IV) non-small cell lung cancer in China.
Findings: PSP-treated patients showed significant improvements in blood leukocyte and neutrophil counts, serum IgG and IgM levels, and percentage of patients maintaining body weight compared to placebo. Quality of life scores were significantly improved in the PSP group, particularly in appetite, fatigue, and pain domains. The study supported PSP as a beneficial adjunct to conventional lung cancer treatment for immune support and quality of life improvement.
Limitations: Chinese patient population. Specific PSP preparation may not be equivalent to all commercial T. versicolor products. Moderate sample size. Advanced-stage cancer patients only. Surrogate immune endpoints rather than overall survival as primary outcome.
[7]
Antioxidant capacity and phenolic profile of Trametes versicolor
Laboratory analysis characterizing the phenolic compound profile and antioxidant capacity of hot water and ethanolic extracts of wild-harvested T. versicolor fruiting bodies using HPLC, DPPH, ABTS, and FRAP assays.
Findings: T. versicolor extracts demonstrated strong antioxidant activity comparable to or exceeding standard antioxidant references. The aqueous extract showed the highest phenolic content, with gallic acid, protocatechuic acid, and catechin identified as major contributors. DPPH radical scavenging activity was dose-dependent, with IC50 values in the low microgram range. The study confirmed that T. versicolor ranks among the highest of medicinal mushrooms for antioxidant capacity and total phenolic content.
Limitations: In vitro study; antioxidant activity in cell-free assays may not directly translate to in vivo antioxidant effects. Wild-harvested specimens from a single geographic location. Antioxidant capacity varies with extraction method, substrate, and growth conditions.
[11]
Hepatoprotective effects of Coriolus versicolor polysaccharides
In vivo study evaluating the hepatoprotective effects of polysaccharide extracts from C. versicolor (T. versicolor) against carbon tetrachloride (CCl4)-induced liver injury in mice.
Findings: Pretreatment with C. versicolor polysaccharides significantly reduced CCl4-induced elevations in serum ALT and AST levels, decreased hepatic lipid peroxidation (MDA levels), and preserved hepatic glutathione (GSH) levels compared to untreated controls. Histological examination confirmed reduced hepatocellular necrosis and inflammatory infiltration. The hepatoprotective activity was attributed to antioxidant and anti-inflammatory properties of the polysaccharide fraction.
Limitations: Animal model (mice). Acute liver injury model may not fully reflect chronic hepatitis conditions. Specific polysaccharide fraction and dose may not be equivalent to commercial products. Single hepatotoxin model (CCl4).
[10]
Preparations & Dosage
Decoction
Strength: 5-15 g dried fruiting body per 500-750 mL water, simmered 45-60 minutes
Add 5-15 g of dried, sliced or powdered turkey tail fruiting bodies to 500-750 mL of cold water. Bring to a gentle boil, then reduce heat and simmer with lid on for 45-60 minutes (extended simmering is necessary to break down chitin and extract cell-wall-bound polysaccharides). Strain through fine mesh. The resulting liquid should be a medium-brown color with a mild, slightly bitter, woody taste. Can be reheated and consumed warm or at room temperature.
250-500 mL decoction daily (equivalent to 5-15 g dried fruiting body), divided into 2-3 servings
2-3 times daily for therapeutic effect
May be used long-term as a daily tonic. For cancer adjuvant support, use throughout the treatment course and recovery period. For immune support, cycles of 2-3 months with periodic reassessment are typical.
Children over 6 years: 100-250 mL daily at half-strength concentration. Not established for younger children.
The traditional and most time-honored preparation method. Extended simmering (at least 45 minutes) is critical for extraction of beta-glucans and other polysaccharides from the tough, chitin-rich cell walls. Unlike delicate herbal infusions, turkey tail requires prolonged heat to be therapeutically active. The decoction can be made in larger batches and refrigerated for 3-4 days. Some practitioners simmer for up to 2-4 hours for maximum extraction. This is the preparation most closely resembling traditional kawaratake tea in Japan.
Capsule / Powder
Strength: Crude dried fruiting body powder: 500 mg per capsule. Concentrated extract: 4:1 to 8:1 DER, 250-500 mg per capsule.
Turkey tail fruiting body powder (finely milled dried fruiting bodies) encapsulated in vegetable cellulose capsules. Higher-quality products use hot water extracted and spray-dried powder to concentrate polysaccharides. Some products combine mycelium and fruiting body. Look for products specifying beta-glucan content and verified by third-party testing.
1-3 g dried fruiting body powder daily in divided doses (typically 2-6 capsules of 500 mg). For cancer adjuvant support, higher doses of 3-9 g daily have been used in clinical settings (Torkelson et al. 2012 used up to 9 g/day).
2-3 times daily, taken with meals
May be used long-term. For cancer support, typically continued throughout treatment and for 6-12 months post-treatment.
Not well-established for children. Some practitioners use 0.5-1 g daily for children over 6 years for immune support. Consult a qualified practitioner.
The most convenient preparation for daily supplementation. Quality varies enormously between products. Key quality markers: (1) beta-glucan content should be specified and verified (aim for >25% beta-glucans), (2) fruiting body-based products are generally preferred over mycelium-on-grain products due to higher polysaccharide content and lower starch content, (3) hot water extraction concentrates bioactive polysaccharides. The Bastyr University phase I trial used whole dried fruiting body powder (not extract) at 3, 6, and 9 g/day.
Standardized Extract
Strength: PSK (Krestin): pharmaceutical-grade protein-bound polysaccharide. PSP: standardized polysaccharopeptide extract. Consumer extracts: standardized to 25-50% beta-glucans, DER typically 8:1 to 15:1.
Pharmaceutical-grade standardized extracts include PSK (Krestin) in Japan and PSP in China. PSK is prepared by hot water extraction of cultured mycelium (CM-101 strain on grain substrate), followed by precipitation and purification to yield a standardized protein-bound polysaccharide powder. PSP is produced by deep-layer fermentation of the COV-1 strain followed by extraction and spray-drying. Consumer-grade standardized extracts specify beta-glucan content (typically 25-50%) or polysaccharide content.
PSK (Krestin): 3 g/day orally in divided doses (standard Japanese pharmaceutical dose used in all major clinical trials). PSP: 3 g/day in divided doses (Chinese clinical trial dose). Consumer-grade standardized extract: 1-3 g daily of extract standardized to >30% beta-glucans.
3 times daily (PSK and PSP: 1 g three times daily)
PSK in Japanese oncology: typically administered for 2-3 years post-surgery in combination with chemotherapy. PSP: similar duration in Chinese protocols. Consumer supplements: ongoing as tolerated.
Not established for standardized extracts in children.
PSK (Krestin) is the gold standard for T. versicolor therapeutics and remains an approved prescription drug in Japan for adjuvant cancer immunotherapy. It is not commercially available as an over-the-counter supplement in most Western countries, though products labeled as PSK equivalents exist. PSP is available as a supplement in China and some Western markets. When using consumer-grade standardized extracts, beta-glucan content (verified by independent testing using the Megazyme assay) is the most reliable quality indicator. Products standardized only to total polysaccharides may include non-bioactive starch from grain substrate.
Tincture
Strength: 1:5 dual extraction (combined aqueous decoction + 60-75% ethanol maceration)
Dual extraction is recommended for T. versicolor tincture. First, prepare a hot water decoction (simmer dried fruiting body in water for 2-4 hours). Separately, macerate dried fruiting body in high-proof ethanol (60-75% ethanol) for 4-6 weeks. Combine the concentrated aqueous decoction with the alcohol extract at a ratio of approximately 60:40 (aqueous to alcohol). This dual-extraction approach captures both water-soluble polysaccharides (beta-glucans, PSK/PSP) and alcohol-soluble compounds (triterpenoids, ergosterol, phenolics).
2-4 mL (40-80 drops) three times daily
Three times daily
May be used for extended periods.
Not well-established. Consult a qualified practitioner.
Dual extraction is important for T. versicolor because the most therapeutically important compounds (beta-glucans and protein-bound polysaccharides) are water-soluble and not efficiently extracted by alcohol alone, while triterpenoids and sterols require alcohol for extraction. A simple alcohol tincture of T. versicolor is therapeutically inadequate as it will miss the primary immunomodulating polysaccharides. The aqueous fraction should constitute the majority of the final tincture.
Syrup
Strength: Concentrated decoction (approximately 30-60 g per 500 mL) combined 1:1 with honey
Prepare a concentrated decoction by simmering 30-60 g dried turkey tail in 1 L of water for 2-4 hours, reducing to approximately 500 mL. Strain thoroughly. Add an equal volume of raw honey (or 1.5 parts honey by weight). Gently warm and stir until fully incorporated. Optionally add 10% brandy or vodka as a preservative. Store in sterilized glass jars in the refrigerator.
1-2 tablespoons (15-30 mL) 2-3 times daily
2-3 times daily
Use within 2-3 months if refrigerated. Discard if fermentation or mold occurs.
Children over 2 years: 1-2 teaspoons (5-10 mL) 1-2 times daily. Not for infants under 1 year due to honey content (botulism risk).
A palatable preparation suitable for those who dislike the taste of decoction or capsules. The honey provides its own antimicrobial and soothing properties. This preparation is common in home herbalism and mycology circles. The concentrated decoction base ensures adequate polysaccharide extraction. Less precise dosing than capsules or standardized extracts.
[3]
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Allergic reactions to T. versicolor are rare but possible. Individuals with known mushroom allergies or sensitivity to fungal spores should exercise caution. Allergic reactions may manifest as skin rash, gastrointestinal upset, or respiratory symptoms. Cross-reactivity with other polypore or basidiomycete fungi is theoretically possible.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Immunosuppressants (cyclosporine, tacrolimus, mycophenolate, azathioprine) (Immunosuppressants) | theoretical | T. versicolor polysaccharides (PSK, PSP, beta-glucans) activate immune cells including T lymphocytes, NK cells, and macrophages through TLR2, Dectin-1, and CR3 pathways. This immune activation could theoretically counteract the intended immune suppression in transplant recipients or patients with autoimmune conditions being treated with immunosuppressive drugs. |
| Cyclophosphamide and other alkylating agents (Cytotoxic chemotherapy) | minor | PSK has been extensively studied as an adjuvant to cyclophosphamide-based chemotherapy regimens in Japanese clinical trials. The interaction is synergistic rather than antagonistic: PSK enhances the immune response activated by cyclophosphamide-induced tumor cell death (immunogenic cell death). PSK also appears to protect against cyclophosphamide-induced immunosuppression by accelerating white blood cell recovery. |
| Tamoxifen and other hormonal cancer therapies (Hormonal anticancer agents) | theoretical | No direct pharmacological interaction documented. The Bastyr University phase I trial (Torkelson et al. 2012) enrolled breast cancer patients, some of whom were taking tamoxifen concurrently, without adverse interactions. However, the combination has not been studied in formal drug interaction studies. |
Pregnancy & Lactation
Pregnancy
insufficient data
Lactation
insufficient data
No clinical studies have evaluated the safety of T. versicolor supplementation during pregnancy or lactation. While turkey tail has a long history of dietary consumption in East Asia and no teratogenic effects have been reported, the potent immunomodulatory activity of PSK and PSP raises theoretical concerns about immune modulation during pregnancy (a state of physiological immune tolerance). Pregnant and lactating women should avoid therapeutic doses of T. versicolor extracts until safety data is available. Occasional dietary consumption of turkey tail in food amounts is unlikely to pose risk but is not well studied.
Adverse Effects
References
Monograph Sources
- [1] American Herbal Pharmacopoeia (AHP). Trametes versicolor (Turkey Tail) — Analytical, Quality Control, and Therapeutic Monograph. American Herbal Pharmacopoeia, Scotts Valley, CA (2017)
- [2] Hobbs C. Medicinal Mushrooms: An Exploration of Tradition, Healing, and Culture. Botanica Press, Santa Cruz, CA (1995) . ISBN: 978-1884360015
- [3] Stamets P. Mycelium Running: How Mushrooms Can Help Save the World. Ten Speed Press, Berkeley, CA (2005) . ISBN: 978-1580085793
Clinical Studies
- [4] Sakamoto J, Morita S, Oba K, Matsui T, Kobayashi M, Nakazato H, Ohashi Y. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother (2006) ; 55 : 404-411 . DOI: 10.1007/s00262-005-0054-1 . PMID: 16133112
- [5] Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet (1994) ; 343 : 1122-1126 . DOI: 10.1016/S0140-6736(94)90233-X . PMID: 7910230
- [6] Torkelson CJ, Sweet E, Martzen MR, Sasagawa M, Wenner CA, Gay J, Bez A, Eng S, Lovy A, Stamets P. Phase 1 clinical trial of Trametes versicolor in women with breast cancer. ISRN Oncol (2012) ; 2012 : 251632 . DOI: 10.5402/2012/251632 . PMID: 22690328
- [7] Yang QY. PSP — A promising immunomodulator from Coriolus versicolor: advance in research and application in China. Int J Med Mushrooms (1999) ; 1 : 93-106
- [8] Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother (2007) ; 56 : 905-911 . DOI: 10.1007/s00262-006-0248-1 . PMID: 17106715
Traditional Texts
- [9] Fritz H, Kennedy DA, Ishii M, Fergusson D, Fernandes R, Cooley K, Seely D. Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review. Integr Cancer Ther (2015) ; 14 : 201-211 . DOI: 10.1177/1534735415572883 . PMID: 25784670
- [10] Chu KKW, Ho SSS, Chow AHL. Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. J Clin Pharmacol (2002) ; 42 : 976-984 . DOI: 10.1177/009127002401102877 . PMID: 12211233
Pharmacopeias & Reviews
- [11] Janjusevic L, Karaman M, Sibul F, Tommonaro G, Iodice C, Jakovljevic D, Grujic N. The lignicolous fungus Trametes versicolor (L.) Lloyd (1920): a promising natural source of antiradical and AChE inhibitory agents. J Enzyme Inhib Med Chem (2017) ; 32 : 355-362 . DOI: 10.1080/14756366.2016.1252759 . PMID: 28097905
Last updated: 2026-03-01 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.